Mickaël Claudel

Dr. Mickaël Claudel

University of Fribourg, Switzerland

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2020 in Chemistry
Verified
Journal Article
Open access
PDF file
MCMickaël Claudel
Mickaël Claudel
JSJustine V. Schwarte
Justine V. Schwarte
Katharina FrommKatharina Fromm
Katharina Fromm
Traditional organic antimicrobials mainly act on specific biochemical processes such as replication, transcription and translation. However, the emergence and wide spread of microbial resistance is a growing threat for human beings. Therefore, it is highly necessary to design strategies for the development of new drugs in order to target multiple cellular processes that should improve their efficiency against several microorganisms, including bacteria, viruses or fungi. The present review is focused on recent advances and findings of new antimicrobial strategies based on metal complexes. Recent studies indicate that some metal ions cause different types of damages to microbial cells as a result of membrane degradation, protein dysfunction and oxidative stress. These unique modes of action, combined with the wide range of three-dimensional geometries that metal complexes can adopt, make them suitable for the development of new antimicrobial drugs.

1 October 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
JFJiahui Fan
Jiahui Fan
MCMickaël Claudel
Mickaël Claudel
CRCarole Ronzani
Carole Ronzani
YAYasmin Arezki
Yasmin Arezki
LLLuc Lebeau
Luc Lebeau
FPFrançoise Pons
Françoise Pons

4 September 2015 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
Pablo BallesterPablo Ballester
Pablo Ballester
MCMickaël Claudel
Mickaël Claudel
SDStéphanie Durot
Stéphanie Durot
LKLucas Kocher
Lucas Kocher
LSLaetitia Schoepff
Laetitia Schoepff
VHValérie Heitz
Valérie Heitz

28 April 2020 in Nanomaterials
Verified
Journal Article
Open access
PDF file
WMWeikun Meng
Weikun Meng
ARAna Rey-Rico
Ana Rey-Rico
MCMickaël Claudel
Mickaël Claudel
GSGertrud Schmitt
Gertrud Schmitt
SSSusanne Speicher-Mentges
Susanne Speicher-Mentges
Magali CucchiariniMagali Cucchiarini
Magali Cucchiarini
Scaffold-assisted gene therapy is a highly promising tool to treat articular cartilage lesions upon direct delivery of chondrogenic candidate sequences. The goal of this study was to examine the feasibility and benefits of providing highly chondroreparative agents, the cartilage-specific sex-determining region Y-type high-mobility group 9 (SOX9) transcription factor or the transforming growth factor beta (TGF-β), to human bone marrow-derived mesenchymal stromal cells (hMSCs) via clinically adapted, independent recombinant adeno-associated virus (rAAV) vectors formulated with carbon dots (CDs), a novel class of carbon-dominated nanomaterials. Effective complexation and release of a reporter rAAV-lacZ vector was achieved using four different CDs elaborated from 1-citric acid and pentaethylenehexamine (CD-1); 2-citric acid, poly(ethylene glycol) monomethyl ether (MW 550 Da), and N,N-dimethylethylenediamine (CD-2); 3-citric acid, branched poly(ethylenimine) (MW 600 Da), and poly(ethylene glycol) monomethyl ether (MW 2 kDa) (CD-3); and 4-citric acid and branched poly(ethylenimine) (MW 600 Da) (CD-4), allowing for the genetic modification of hMSCs. Among the nanoparticles, CD-2 showed an optimal ability for rAAV delivery (up to 2.2-fold increase in lacZ expression relative to free vector treatment with 100% cell viability for at least 10 days, the longest time point examined). Administration of therapeutic (SOX9, TGF-β) rAAV vectors in hMSCs via CD-2 led to the effective overexpression of each independent transgene, promoting enhanced cell proliferation (TGF-β) and cartilage matrix deposition (glycosaminoglycans, type-II collagen) for at least 21 days relative to control treatments (CD-2 lacking rAAV or associated to rAAV-lacZ), while advantageously restricting undesirable type-I and -X collagen deposition. These results reveal the potential of CD-guided rAAV gene administration in hMSCs as safe, non-invasive systems for translational strategies to enhance cartilage repair.

7 March 2019 in RSC Advances
Verified
Journal Article
Open access
PDF file
MCMickaël Claudel
Mickaël Claudel
JFJiahui Fan
Jiahui Fan
MRMickaël Rapp
Mickaël Rapp
FPFrançoise Pons
Françoise Pons
LLLuc Lebeau
Luc Lebeau
Correction for ‘Influence of carbonization conditions on luminescence and gene delivery properties of nitrogen-doped carbon dots’ by Mickaël Claudel et al., RSC Adv., 2019, 9, 3493–3502.